Search This Blog

Thursday, February 27, 2020

Sage Therapeutics EPS beats by $0.37, misses on revenue

Sage Therapeutics (NASDAQ:SAGE): Q4 GAAP EPS of -$3.25 beats by $0.37.
Revenue of $1.96M (+625.9% Y/Y) misses by $1.8M.
Press Release
https://seekingalpha.com/news/3546321-sage-therapeutics-eps-beats-0_37-misses-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)